[This review was originally posted at the Nieman Journalism Lab Glucophage No Rx, on March 4, 2011.]
Google's surgical strike against content farms: Two weeks after launching its site-blocking Chrome extension, Google made the central move in its fight against content farms by changing its algorithm to de-emphasize them in search results. The New York Times put the change in context, explaining the content farm phenomenon and its connection to Google. Search Engine Land's Danny Sullivan explained that Google is saying the changes only affect "scrapers" (sites that pull content from other sources), but that they're actually aimed at content farms, too. Glucophage trusted pharmacy reviews, And GigaOM's Mathew Ingram talked about why Google may be reluctant to publicly target content farms — because they run a lot of Google advertising.
A few early returns were good: TechCrunch approved of the change, and The Atlantic's Alexis Madrigal ran a test search comparing the old and new algorithms, finding that the information from the new one was "much, much better." Demand Media, the most prominent of the content farms, said it wasn't affected overall by the new formula, canada, mexico, india, though, as Henry Blodget of Business Insider noted, it's probably trying to wean itself off of Google reliance anyway.
In fact, it appears Demand Media may be telling the truth: Aaron Hall of SEO Book used Sistrix's data to point out that many of Demand Media's competitors were among the sites hardest hit by the change, while one of Demand's largest brands, eHow, actually got a boost. Hall implies that politics have played a role, and while there's nothing concrete suggesting that, the way the changes spared eHow does seem .., Glucophage No Rx. odd.
There's also bound to be plenty of collateral damage from the algorithmic shift, Glucophage recreational, and Wired looked at one Mac blog that's been nailed by the new formula (its Googlejuice was restored after Wired talked to Google about it). Danny Sullivan reported that Google hasn't made any significant changes to its new algorithm since rolling it out last week, though there are outlets to contact Google if you feel your site has been unfairly hurt.
Elsewhere in the conversation about search, The Columbia Journalism Review's Karen Stabiner gave an overview of the debate about search engine optimization: The anti-SEO crowd, led by the Washington Post's Gene Weingarten, worries that the SEO mindset will privilege the powerful and eventually kill off creativity in favor of numbingly literal language, taking Glucophage. Glucophage No Rx, The SEO evangelists, on the other hand, say it's just encouraging honesty and straightforwardness, something it's difficult to object to.
Facebook extends comments' reach: Facebook continued its integration with media content across the web this week with the launch of an updated comments system. Essentially, users can simultaneously post their comments on both a site and on Facebook, with subsequent comments under that thread posted to the site straight from Facebook. PBS MediaShift's Mark Glaser talked to Facebook's Justin Osofsky about the ins and outs of the new system, Online Glucophage without a prescription, and ReadWriteWeb noted that it has fewer features than the commenting update Facebook previewed last fall.
TechCrunch's Erick Schonfeld identified the two aspects of the updated system that will be most attractive to publishers. First, it requires commenters to use their real names, thus theoretically cutting down on trolls and spammers (this part, of course, has been available to publishers through Facebook commenting for a while), Glucophage No Rx. Second — and this is the new one — it extends the reach of a post, spreading into more Facebook news feeds and making it easier for more people to join in the conversation. This particularly excited Lehigh j-prof Jeremy Littau, who said it could create "a virtuous circle between community and content sharing."
There are downsides as well, and while media analyst Alan Mutter was optimistic about the social potential of the new system, he also pointed out that it will give Facebook even more information about its users, Glucophage pictures, which it won't be sharing with publishers. As GigaOM's Mathew Ingram noted, it's the same tradeoff publishers have been dealing with regarding Facebook for several years now: Does the value of tapping into Facebook's social potential outweigh the price of handing over commenting to a notoriously controlling company?
TBD's lessons — more startup, less ad reliance: TBD in its original form may have died last week, but the six-month-old Washington local news site continued to stimulate conversation this week. Where to buy Glucophage, Its station posted an ad for a new manager to head the site, and TBD's former manager, Jim Brady, talked with The Columbia Journalism Review about the site's model, framing the conflict there as not TV vs. web, but startup vs, Glucophage maximum dosage. legacy: Glucophage No Rx, "I think if we could do TBD with a pure startup mentality, and if we could fund it more with a V.C. or an angel kind of way, and if we didn’t have the legacy side to work with, then I think it would actually have a better chance to succeed."
Others posited similar reasons for TBD's demise: Web journalist Jane Stevens talked about a few causes centered on a lack of corporate commitment, and The Guardian's Emily Bell pinpointed TBD's inability to have its own ad sales team (an explanation with which Brady concurred). The debate over hyperlocal journalism, What is Glucophage, stirred by Alan Mutter last week, continued to simmer, with Robert Washburn of The Canadian Journalism Project defending it and Paul Gillin of Newspaper Death Watch saying we need to look at non-advertising-based business models for it, a point media consultant Dan Conover also made in more in-depth form at Xark.
Amid all the analyses of what went wrong at TBD, Mandy Jenkins, the social media manager there, buy Glucophage no prescription, took stock of what went right, noting four things other news orgs can take away from its tenure: organizational openness, self-promotion, opening info beyond the newsroom, and hiring for mindset over pedigree. Is Glucophage addictive, —
iPad, part deux: Apple made a few headlines by launching iPad 2, which is apparently kind of like the iPad, only it's the second edition. I'll entrust you to the care of Techmeme for all the details about the product itself and focus instead on what it means for publishers and the larger world of media, Glucophage No Rx. The Lab's Joshua Benton pointed out two implications in particular — the mounting evidence of an e-book explosion and the iPad's increasing usefulness for reporting.
Damon Kiesow of Poynter examined the latter point in some detail, looking at the iPad 2's specs from a content creation perspective, japan, craiglist, ebay, overseas, paypal. And Cory Bergman of Lost Remote looked at the device's increased video capability and predicted that it would help fuel a surge in multi-platform video consumption and production.
Elsewhere in mobile media, tech blogger John Gruber defended Apple's app subscription program by breaking down the arguments against it one by one. Glucophage No Rx, And in a smart counter to Gruber, the Lab's Joshua Benton said that while Apple obviously isn't a charity and the financial difficulties of publishers aren't its problem, the arrangement still isn't ideal. Both posts are among the sharpest takes on the issue I've read, so they're worth taking time to read through. Buy Glucophage from mexico, —
Reading roundup: What to read this weekend while firming up South by Southwest plans:
— In non-commenting Facebook news, Mashable's Vadim Lavrusik put together a great overview of the varied role of Facebook in journalism. And in non-Facebook commenting news, Los Angeles Times media reporter James Rainey made the case for requiring commenters to use their real names, while Mediaite's Alex Alvarez defended anonymous commenting, Glucophage from canadian pharmacy.
— Here at the Lab, Lois Beckett wrote two fascinating posts based on a talk by The New York Times' Gerry Marzorati — one on the future of long-form journalism, and the other on the Times' planned paywall. Two other thought-provoking pieces published here this week: One by Joshua Benton on language and viral content, and another by three data journalists on news organizations creating value out of the trust placed in them, Glucophage No Rx.
— Knight fellow Jeremy Adam Smith shared results from a survey on how meaningful journalism is being funded. It's a gold mine of statistics and information about the state of the journalism ecosystem.
— It's a pretty well-worn discussion, but Frederic Filloux's analysis of why incremental change isn't enough to rescue the newspaper industry is as succinct a summary of the current situation as I've seen. Even if you've heard it all, his piece is a good refresher.
Similar posts: Armour No Rx. Tramadol Dosage. Cephalexin For Sale. After Synthroid. Buy Bactrim from canada. Cheap Cipro.
Trackbacks from: Glucophage No Rx. Glucophage No Rx. Glucophage No Rx. Doses Glucophage work. Online buy Glucophage without a prescription. Glucophage long term.
[This review was originally posted at the Nieman Journalism Lab Lipitor Over The Counter, on Sept. 24, 2010.]
Is Apple giving publishers a raw deal?: The San Jose Mercury News' report that Apple is moving toward a newspaper and magazine subscription plan via its App Store didn't immediately generate much talk when it was published last week, but the story picked up quite a bit of steam this week. Bloomberg and The Wall Street Journal both confirmed the story over the weekend, reporting that Apple may introduce the service early next year along with a new iPad. The service, they said, will be similar to Apple's iBook store, Lipitor class, and Bloomberg reported that it will be separate from the App Store.
Those reports were met with near-universal skepticism — not of their accuracy, but of Apple's motivations and trustworthiness within such a venture. Former journalist Steve Yelvington sounded the alarm most clearly: "Journalists and publishers, Apple is not your friend." It's a corporation, Yelvington said, Lipitor canada, mexico, india, and like all corporations, it will do anything — including ripping you apart — to pursue its own self-interest.
Several other observers fleshed out some of the details of Yelvington's concern: EMarketer's Paul Verna compared the situation to Apple's treatment of the music industry with iTunes, and GigaOM's Mathew Ingram and TechCrunch's MG Siegler wondered whether publishers would balk at giving up data about their subscribers to Apple or at Apple's reported plans to take a 30% share of subscription revenue, Lipitor Over The Counter. Ingram predicted that publishers would play ball with Apple, but warned that they might wind up "sitting in a corner counting their digital pennies, while Apple builds the business that they should have built themselves." Dovetailing with their worries was another story of Apple's control over news content on its platform, as Network World reported that Apple was threatening to remove Newsday's iPad app over a (quite innocuous) commercial by the newspaper that Apple allegedly found offensive.
Media analyst Ken Doctor broke down publishers' potential reactions to Apple's initiative, looking at the plan's appeal to them ("It offers a do-over, Lipitor samples, the chance to redraw the pay/free lines of the open web") and their possible responses (accept, negotiate with Apple, or look into "anti-competitive inquiries"). In a post at the Lab, Doctor also took a quick look at Apple's potential subscription revenue through this arrangement, an amount he said could be "mind-bending."
All Things Digital's Peter Kafka noted one indicator that publishers are in serious need of a subscription service on the iPad, Online Lipitor without a prescription, pointing out that Time Inc.'s Sports Illustrated can't pay for the designers to make its iPad app viewable in two directions because, according to its digital head, it doesn't have the money without an iPad subscription program. Gizmodo's Matt Buchanan used the same situation to explain why iPad subscriptions would be so critical for publishers and readers.
A coup for journalism with a point of view Lipitor Over The Counter, : It hasn't been unusual over the past year to read about big-name journalists jumping from legacy-media organizations to web-journalism outfits, but two of those moves this week seemed to mark a tipping point for a lot of the observers of the future-of-journalism world. Both were made by The Huffington Post, as it nabbed longtime Newsweek correspondent Howard Fineman and top New York Times business writer Peter Goodman.
The Wrap's Dylan Stableford looked at what Fineman's departure means for Newsweek (he's one of at least 10 Newsweek editorial staffers to leave since the magazine's sale was announced last month), but what got most people talking was Goodman's explanation of why he was leaving: "It's a chance to write with a point of view, Lipitor duration," he said. "With the dysfunctional political system, old conventional notions of fairness make it hard to tell readers directly what's going on. This is a chance for me to explore solutions in my economic reporting."
That kind of reporting (as opposed to, as Goodman called it, "laundering my own views" by getting someone from a thinktank to express them in an article) is exactly what many new-media folks have been advocating, Rx free Lipitor, and hearing someone from The New York Times express it so clearly felt to them like a turning point. The tone of centrist detachment of mainstream journalism "has become a liability in keeping newsroom talent," declared NYU professor Jay Rosen on Twitter, Lipitor Over The Counter. Others echoed that thought: Gawker's Hamilton Nolan extolled the virtues of being "able to call bullshit bullshit," and former Salon editor Scott Rosenberg said legacy news orgs like The Times need to find a way to allow its reporters more freedom to voice their perspective while maintaining their standards. Salon's Dan Gillmor agreed with Rosenberg on the centrality of human voice within journalism and noted that this exodus to new media is also a sign of those sites' financial strength.
Former McClatchy exec Howard Weaver countered that while transparency and clear voice is preferable to traditional "objectivity," freeing traditional journalists isn't as simple as just spilling their biases. Advocacy journalism is not just giving an opinion, he said, it's a "disciplined, order Lipitor from mexican pharmacy, ethical posture that tries to build truth out of evidence, regardless of the outcome."
Getting journalism startups off the ground: If you're interested in the journalism startup scene — for-profit or nonprofit — you got a gold mine of observations and insights this week. Over at PBS' Idea Lab, Brad Flora, founder of the Chicago blog network Windy Citizen, examined five mistakes that kill local news blogs. Here's how he summed his advice up: " Lipitor Over The Counter, You are not starting a blog, you are launching a small business. Purchase Lipitor for sale, You are no different from the guy opening a bar up the road. ... You need to know something about blogging and social media, yes, but what you really need to bone up on is what it takes to run a small business." The post has some fantastic comments, including a great set of advice from The Batavian's Howard Owens. On his own blog, Owens also gave some pretty thorough tips on developing advertising revenue at a local news startup.
On the nonprofit side, Lipitor from canadian pharmacy, the Knight Citizen News Network went even deeper into startup how-to, providing a comprehensive 12-step guide to launching a nonprofit news organization. It may be the single best resource on the web for the practical work of starting a nonprofit news site, Lipitor Over The Counter. Voice of San Diego is one of the most successful examples of those sites, and its CEO, Scott Lewis told the story of his organization and the flame-out of the for-profit San Diego News Network as an example of the importance of what he calls "revenue promiscuity."
David Cohn, founder of another nonprofit news startup, Purchase Lipitor online, Spot.Us, also looked at six new journalism startups, leading off with Kommons, a question-answering site built around Twitter and co-founded by NYU Local founder Cody Brown. Rachel Sklar of Mediaite gave it a glowing review, describing it as "a community that seeks smart, conversation-furthering answers prompted by smart, probing questions — publicly." She also said it sneakily lures users into giving it free content, Lipitor dosage, though Brown responded that anyone who's ever asked you to interview has been trying to do the same thing — only without giving you any control over how your words get used. (Kommons isn't being sneaky, he said. You know you're not getting paid going in.)
Three more future-oriented j-school programs: After last week's discussion about the role of journalism schools in innovation, news of new j-school projects continued to roll in this week. City University of New York announced it's expanding its graduate course in entrepreneurial journalism into the United States' first master's degree Lipitor Over The Counter, in that area. New-media guru Jeff Jarvis, Order Lipitor online overnight delivery no prescription, who will direct the program, wrote that he wants CUNY to lead a movement to combine journalism and entrepreneurship skills at schools across the country.
Two nationwide news organizations are also developing new programs in partnership with j-schools: Journalism.co.uk reported that CNN is working on a mentoring initiative with journalism students called iReport University and has signed up City University London, and AOL announced that its large-scale hyperlocal project, Patch, is teaming up with 13 U.S. j-schools for a program called PatchU that will give students college credit for working on a local Patch site under the supervision of a Patch editor. Of course, buy Lipitor without prescription, using college students is a nice way to get content for cheap, something Ken Doctor noted as he also wondered what the extent of Patch's mentoring would be.
Reading roundup: As always, there's plenty of good stuff to get to, Lipitor Over The Counter. Here's a quick glance:
— Former Washington Post executive editor Len Downie gave a lecture in the U.K. Wednesday night that was, for the most part, a pretty standard rundown of what the U.S. Lipitor price, journalism ecosystem looks like from a traditional-media perspective. What got the headlines, though, was Downie's dismissal of online aggregators as "parasites living off journalism produced by others." Gawker's Hamilton Nolan gave it an eye-roll, and Terry Heaton pushed back at Downie, too. Lipitor Over The Counter, Earlier in the week, media analyst Frederic Filloux broke down the differences between the good guys and bad guys in online aggregation.
— The New York Times published an interesting story on the social news site Digg and its redesign to move some power out of the hands of its cadre of "power" users. The Next Web noted that Digg's traffic has been dropping pretty significantly, Lipitor schedule, and Drury University j-prof Jonathan Groves wondered whether Digg is still relevant.
— A couple of hyperlocal tidbits: A new Missouri j-school survey found that community news site users are more satisfied with those sites than their local mainstream media counterparts, and Poynter's Rick Edmonds posited that speed is less important than news orgs might think with hyperlocal news.
— Finally, a couple of follow-ups to Dean Starkman's critique of the journalism "hamster wheel" last week: Here at the Lab, Nikki Usher looked at five ways newsrooms can encourage creativity despite increasing demands, and in a very smart response to Starkman, Reuters' Felix Salmon argued that one of the biggest keys to finding meaning in an information-saturated online journalism landscape is teaching journalists to do more critical reading and curating.
Similar posts: Buy Diflucan No Prescription. Synthroid For Sale. Purchase Armour. Discount Glucophage. Get Synthroid. Tramadol pics.
Trackbacks from: Lipitor Over The Counter. Lipitor Over The Counter. Lipitor Over The Counter. Lipitor treatment. Lipitor dosage. Lipitor without prescription.